World's Best Scientists 2026 revealed!
Peter C. Harris

Peter C. Harris

D-Index & Metrics

Medicine

D-Index
108
Citations
44137
World Ranking
5993
National Ranking
3203

Overview

Peter C. Harris is affiliated with the Mayo Clinic in the United States and has contributed extensively to the fields of Biochemistry, Genetics, and Molecular Biology, with additional work in Medicine.

Their research spans several subfields including Genetics, Molecular Biology, Pathology and Forensic Medicine, Nephrology, and Pulmonary and Respiratory Medicine. The primary focus lies on Genetic and Kidney Cyst Diseases, Renal and related cancers, Genetic Syndromes and Imprinting, Biomedical Research and Pathophysiology, Renal Diseases and Glomerulopathies, Kidney Stones and Urolithiasis Treatments, and Pediatric Urology and Nephrology Studies.

Frequent co-authors collaborating with Peter C. Harris include:

  • Vicente E. Torres
  • Fouad T. Chebib
  • Christian Hanna
  • John C. Lieske
  • Timothy L. Kline

Their publications are often found in the following venues:

  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Kidney International
  • Nephrology Dialysis Transplantation
  • Kidney360

Some of their recent papers include:

  • "The genetics of kidney stone disease and nephrocalcinosis" (2021) published in Nature Reviews Nephrology
  • "Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference" (2022) published in Kidney International
  • "Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype" (2021) published in The American Journal of Human Genetics
  • "The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD" (2020) published in JCI Insight
  • "Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)" (2021) published in Kidney International

Best Publications

  • Identification and characterization of the tuberous sclerosis gene on chromosome 16

    Mark Nellist;Bart Janssen;Phillip T. Brook-Carter;Arjenne L. W. Hesseling-Janssen

  • Autosomal dominant polycystic kidney disease

    Vicente E Torres;Peter C Harris;Yves Pirson

  • Polycystic Kidney Disease

    Peter C. Harris;Vicente E. Torres

  • Volume Progression in Polycystic Kidney Disease

    Jared J. Grantham;Vicente E. Torres;Arlene B. Chapman;Lisa M. Guay-Woodford

  • Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

    Vincent H Gattone;Xiaofang Wang;Peter C Harris;Vicente E Torres

  • The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

    Christopher J. Ward;Marie C. Hogan;Sandro Rossetti;Denise Walker

  • Autosomal dominant polycystic kidney disease: the last 3 years

    Vicente E. Torres;Peter C. Harris

  • Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.

    Vicente E Torres;Xiaofang Wang;Qi Qian;Stefan Somlo

  • Polycystic kidney disease.

    Carsten Bergmann;Lisa M. Guay-Woodford;Peter C. Harris;Shigeo Horie

  • Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials

    María V. Irazabal;Laureano J. Rangel;Eric J. Bergstralh;Sara L. Osborn

  • Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - A contiguous gene syndrome

    Phillip T. Brook-Carter;Belén Peral;Christopher J. Ward;Peter Thompson

  • Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel

    Silvia González-Perrett;Keetae Kim;Cristina Ibarra;Alicia E. Damiano

  • Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

    Robert W. Schrier;Robert W. Schrier;Kaleab Z. Abebe;Ronald D. Perrone;Vicente E. Torres

  • Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

    Sandro Rossetti;Mark B. Consugar;Arlene B. Chapman;Vicente E. Torres

  • Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene

    Julian R. Sampson;Magitha M. Maheshwar;Richard Aspinwall;Peter Thompson

  • Effectiveness of Vasopressin V2 Receptor Antagonists OPC-31260 and OPC-41061 on Polycystic Kidney Disease Development in the PCK Rat

    Xiaofang Wang;Vincent Gattone;Peter C. Harris;Vicente E. Torres

  • Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease

    Arlene B. Chapman;James E. Bost;Vicente E. Torres;Lisa Guay-Woodford

  • Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity

    Katharina Hopp;Christopher J. Ward;Cynthia J. Hommerding;Samih H. Nasr

  • Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases

    Vicente E Torres;Peter C Harris

  • Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

    Marie C. Hogan;Tetyana V. Masyuk;Linda J. Page;Vickie J. Kubly

Frequent Co-Authors

Arlene B. Chapman
Arlene B. Chapman University of Chicago
Kyongtae T. Bae
Kyongtae T. Bae University of Pittsburgh
Jared J. Grantham
Jared J. Grantham University of Kansas
John C. Lieske
John C. Lieske Mayo Clinic
Stefan Somlo
Stefan Somlo Yale University
Douglas R. Higgs
Douglas R. Higgs University of Oxford
Julian Roy Sampson
Julian Roy Sampson Cardiff University
Martijn H. Breuning
Martijn H. Breuning Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a wide array of online degrees and healthcare career pathways. For current registered nurses looking to advance, finding the cheapest accredited online rn to bsn programs can help reduce the cost of further education while boosting career prospects.

Those with non-nursing backgrounds who are drawn to healthcare might consider online direct entry msn programs for non-nursing majors. These programs are designed for career changers eager to earn an advanced nursing degree efficiently.

If entry barriers are a concern, some candidates may benefit from researching easy nursing programs to get into. Such programs can offer alternative pathways into nursing, often with more flexible admissions requirements.

For individuals interested in healthcare administration or non-clinical roles, earning a credential from one of the top medical billing and coding online schools provides valuable skills applicable in hospitals and insurance companies.

Whether you aim for patient care or support positions, these diverse online programs can set the foundation for a successful healthcare career.

Best Scientists Citing Peter C. Harris

Trending Scientists

Recently Published Articles